[Featured Stock] Prestige Biologics Shows Strength on First Day of Listing
[Asia Economy Reporter Jang Hyowon] Prestige Biologics, a contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, is showing strong performance on its first day of listing.
As of 9:36 AM on the 11th, Prestige Biologics is trading at 13,450 KRW, up 11.16% from the opening price. The opening price was set at 12,100 KRW, which is lower than the public offering price of 12,400 KRW.
Prestige Biologics had a subscription competition rate of 126.06 to 1, with a total public offering of 7.35 million shares, resulting in a total public offering amount of 91.14 billion KRW.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Prestige Biologics plans to actively use the public offering funds to develop new manufacturing platforms and services to secure orders for next-generation products.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
